Indivior Pharmaceuticals (INDV) Net Equity Issued and Repurchased (2024 - 2025)

Indivior Pharmaceuticals' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed 0.0% year-over-year to $1.0 million in Q3 2025; TTM through Mar 2026 was $1.0 million, a 50.0% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 33.33% from the prior year.
• Net Equity Issued and Repurchased steadied at $1.0 million in Q3 2025 per INDV's latest filing, from $1.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $2.0 million in Q1 2024 and bottomed at $1.0 million in Q3 2024.